BRAINLIFE.ORG





Neuro-Oncology Reviews




Volume 26 Number 13
10 July 2024




Home > Publications > Neuro-Oncology Reviews > Volume 26, Year 2024 > Number 13, 10 July






Miramova A, Gartner A, Ivanov D.
How to sensitize glioblastomas to temozolomide chemotherapy: a gap-centered view.
Front Cell Dev Biol. 2024 Jul 1;12:1436563. doi: 10.3389/fcell.2024.1436563. PMID: 39011394. Review. ˍ




Menna G, Marinno S, Valeri F, Mahadevan S, Mattogno PP, Gaudino S, Olivi A, Doglietto F, Berger MS, Della Pepa GM.
Diffusion tensor imaging in detecting gliomas sub-regions of infiltration, local and remote recurrences: a systematic review.
Neurosurg Rev. 2024 Jul 2;47(1):301. doi: 10.1007/s10143-024-02529-3. PMID: 38954077. Review˰ ˍ




Palizkaran Yazdi M, Barjasteh A, Moghbeli M.
MicroRNAs as the pivotal regulators of Temozolomide resistance in glioblastoma.
Mol Brain. 2024 Jul 2;17(1):42. doi: 10.1186/s13041-024-01113-6. PMID: 38956588. Review. ˍ




Sepulveda F, Scotto Opipari R, Coppola F, Ramaglia A, Mankad K, Alves CAP, Bison B, Löbel U.
Approaches to supratentorial brain tumours in children.
Neuroradiology. 2024 Jul 2. doi: 10.1007/s00234-024-03398-9. PMID: 38953989. Review˰ ˍ




Wei S, Chang L, Zhong Y.
The efficacy and adverse events of bevacizumab combined with temozolomide in the treatment of glioma: a systemic review and meta-analysis of randomized controlled trials.
Front Med (Lausanne). 2024 Jul 2;11:1419038. doi: 10.3389/fmed.2024.1419038. PMID: 39015784. Review; Meta-analysis. ˍ




Baker CR, Pease M, Sexton DP, Abumoussa A, Chambless LB.
Artificial intelligence innovations in neurosurgical oncology: a narrative review.
J Neurooncol. 2024 Jul 3. doi: 10.1007/s11060-024-04757-5. PMID: 38958849. Review. ˍ




Chatterjee D, Bhattacharya S, Kumari L, Datta A.
Aptamers: ushering in new hopes in targeted glioblastoma therapy.
J Drug Target. 2024 Jul 3:1-24. doi: 10.1080/1061186X.2024.2373306. PMID: 38923419. Review˰ ˍ




McBriar JD, Shafiian N, Scharf S, Boockvar JA, Wernicke AG.
Prostate-Specific Membrane Antigen Use in Glioma Management: Past, Present, and Future.
Clin Nucl Med. 2024 Jul 3. doi: 10.1097/RLU.0000000000005365. PMID: 38968568. Review˰ ˍ




Tataranu LG, Turliuc S, Rizea RE, Dricu A, Alexandru O, Staicu GA, Kamel A.
A Synopsis of Biomarkers in Glioblastoma: Past and Present.
Curr Issues Mol Biol. 2024 Jul 3;46(7):6903-6939. doi: 10.3390/cimb46070412. PMID: 39057054. Review. ˍ




Sheikh SR, Patel NJ, Recinos VM.
Safety and Technical Efficacy of Pediatric Brainstem Biopsies: An Updated Meta-Analysis of 1000+ Children.
World Neurosurg. 2024 Jul 4:S1878-8750(24)01139-2. doi: 10.1016/j.wneu.2024.06.163. PMID: 38968995. Meta-analysis. ˍ




Papadimitrakis D, Perdikakis M, Gargalionis AN, Papavassiliou AG.
Biomarkers in Cerebrospinal Fluid for the Diagnosis and Monitoring of Gliomas.
Biomolecules. 2024 Jul 5;14(7):801. doi: 10.3390/biom14070801. PMID: 39062515. Review. ˍ




Sanvito F, Castellano A, Cloughesy TF, Wen PY, Ellingson BM.
RANO 2.0 criteria: concepts applicable to the neuroradiologist's clinical practice.
Curr Opin Oncol. 2024 Jul 5. doi: 10.1097/CCO.0000000000001077. PMID: 39011735. Review˰ ˍ




*Scheepens JCC, Taphoorn MJB, Koekkoek JAF.
Patient-reported outcomes in neuro-oncology.
Curr Opin Oncol. 2024 Jul 5. doi: 10.1097/CCO.0000000000001078. PMID: 38984633. Review. ˍ




Galldiks N, Lohmann P, Friedrich M, Werner JM, Stetter I, Wollring MM, Ceccon G, Stegmayr C, Krause S, Fink GR, Law I, Langen KJ, Tonn JC.
PET imaging of gliomas: Status quo and quo vadis?
Neuro Oncol. 2024 Jul 6:noae078. doi: 10.1093/neuonc/noae078. PMID: 38970818. Review˰ ˍ




Sættem M, Sundstrøm T, Sæle AKM, Mahesparan R.
Review of metastasis to meningiomas with case examples.
Brain Spine. 2024 Jul 6;4:102862. doi: 10.1016/j.bas.2024.102862. PMID: 39099765. Case report; Review. ˍ




*Ng ZX, Koh ES, Lee SF, Tan CL, Teo K, Wong A, Lo SS, Vellayappan B.
A systematic review and meta-analysis informing the role of adjuvant radiotherapy (RT) in Grade 2 and 3 oligodendroglioma.
J Clin Neurosci. 2024 Jul 8;126:247-255. doi: 10.1016/j.jocn.2024.06.020? PMID: 38981364. Review; Meta-analysis˰ ˍ




Vassantachart AK, Ehret F, Chen E, Kumar R, Gogineni E, Andraos TY, Sahgal A, Redmond KJ, Lo SS, Chang EL, Sheehan J, Chao ST, Kim GG, Kresl JJ, Schulder M, Palmer JD, Gibbs IC, Santacroce A, Shih HA.
A Case-based Guide for World Health Organization (WHO) Grade 2 Meningioma Radiosurgery and Radiation Therapy from The Radiosurgery Society.
Pract Radiat Oncol. 2024 Jul 8:S1879-8500(24)00090-0. doi: 10.1016/j.prro.2024.02.009. PMID: 38970567. Guidelines˰ ˍ




Khaboushan AS, Ohadi MAD, Amani H, Dashtkoohi M, Iranmehr A, Sheehan JP.
Stereotactic radiosurgery for intraventricular meningioma: a systematic review and meta-analysis.
Acta Neurochir (Wien). 2024 Jul 9;166(1):286. doi: 10.1007/s00701-024-06185-w. PMID: 38980438. Review; Meta-analysis. ˍ




Li X, Gou W, Zhang X.
Neuroinflammation in Glioblastoma: Progress and Perspectives.
Brain Sci. 2024 Jul 9;14(7):687. doi: 10.3390/brainsci14070687. PMID: 39061427. Review. ˍ




Librizzi G, Lombardi G, Bertoldo A, Manara R.
Perioperative imaging predictors of tumor progression and pseudoprogression: A systematic review.
Crit Rev Oncol Hematol. 2024 Jul 9;202:104445. doi: 10.1016/j.critrevonc.2024.104445. PMID: 38992848. Review. ˍ




Sherman JH, Bobak A, Arsiwala T, Lockman P, Aulakh S.
Targeting drug resistance in glioblastoma (Review).
Int J Oncol. 2024 Jul 9;65(2):80. doi: 10.3892/ijo.2024.5668. PMID: 38994761. Review. ˍ




Wang M, Peng Y, Wang Y, Luo D.
Research Trends and Evolution in Radiogenomics (2005-2023): Bibliometric Analysis.
Interact J Med Res. 2024 Jul 9;13:e51347. doi: 10.2196/51347. PMID: 38980713. Bibliometric analysis. ˍ




Yin J, Liu G, Zhang Y, Zhou Y, Pan Y, Zhang Q, Yu R, Gao S.
Gender differences in gliomas: From epidemiological trends to changes at the hormonal and molecular levels.
Cancer Lett. 2024 Jul 9;598:217114. doi: 10.1016/j.canlet.2024.217114. PMID: 38992488. Review˰ ˍ




Bhanja D, James JG, McNutt S, Kray K, Rizk E.
Awake craniotomy in pediatric low-grade glioma: barriers and future directions.
Childs Nerv Syst. 2024 Jul 10. doi: 10.1007/s00381-024-06457-x. PMID: 38985318. Review˰ ˍ




Rossi F, Botti S, Morri M, Asaftei S, Bertin D, Breggiè S, Casalaz R, Cervo M, Ciullini P, Coppo M, Cornelli A, Esposito M, Ferrarese M, Ghetti M, Longo L, Naretto G, Orsini N, Panzeri D, Pellegrini C, Peranzoni M, Perna A, Petit N, Picone F, Pittorru G, Raffa D, Recchiuti V, Rizzato L, Sarzana M, Sensi R, Fagioli F, Ricci F.
The Italian Consensus Conference on the role of rehabilitation for children and adolescents with leukemia, central nervous system tumors, and bone cancer, part 2: general principles for the rehabilitation treatment of motor function impairments.
Pediatr Hematol Oncol. 2024 Jul 10:1-21. doi: 10.1080/08880018.2024.2353360. PMID: 38984654. Meeting report˰ ˍ




Shen S, Wang S, Zhou D, Wu X, Gao M, Wu J, Yang Y, Pan X, Wang N.
A clinician's perspective on boron neutron capture therapy: promising advances, ongoing trials, and future outlook.
Int J Radiat Biol. 2024 Jul 10:1-17. doi: 10.1080/09553002.2024.2373746. PMID: 38986056. Review. ˍ